Molecular and immunohistochemical characterization of ERBB2 activating mutations in low-grade serous ovarian carcinoma.

Saved in:
Bibliographic Details
Title: Molecular and immunohistochemical characterization of ERBB2 activating mutations in low-grade serous ovarian carcinoma.
Authors: Neil AJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Nkosi D; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pathology, University of Rochester Medical Center, University of Rochester School of Medicine, Rochester, NY, USA., Yoon JY; Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Kolin DL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Source: Histopathology [Histopathology] 2025 Aug; Vol. 87 (2), pp. 310-320. Date of Electronic Publication: 2025 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2559
DOI:10.1111/his.15452